Familial pancreatic cancer: Genetic advances

Genes and Development

Volumn 28, Issue 1, 2014, Pages 1-7

  Rustgi, Anil K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

BRCA2; Familial pancreatic cancer; Genetic testing; Hereditary pancreatitis

Indexed keywords

ALCOHOL; ATM PROTEIN; BRCA2 PROTEIN; CHYMOTRYPSIN C; CYCLIN DEPENDENT KINASE 2; MISMATCH REPAIR PROTEIN PMS2; MITOGEN ACTIVATED PROTEIN KINASE; MITOMYCIN; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; STRESS ACTIVATED PROTEIN KINASE; TRYPSINOGEN; UNCLASSIFIED DRUG;

CELL CYCLE PROGRESSION; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DNA REPAIR; DNA SEQUENCE; FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA SYNDROME; FAMILIAL CANCER; FAMILIAL COLON POLYPOSIS; FAMILIAL PANCREAS CANCER; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; GENOMIC INSTABILITY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HETEROZYGOSITY LOSS; HUMAN; MULTIPLE CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PANCREATITIS; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; REVIEW; SISTER CHROMATID; SMOKING;

EID: 84891691973     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.228452.113     Document Type: Review

References (48)

1. Al-Sukhni W., Joe S, Lionel AC, Zwingerman N, Zogopoulos G, Marshall CR, Borgida A, Holter S, Gropper A, Moore S, et al. 2012. Identification of germline genomic copy number variation in familial pancreatic cancer. Hum Genet 131: 1481-1494.
2. Amundadottir L., Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, et al. 2009. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 41: 986-990.
3. Archer H., Jura N, Keller J, Jacobson M, Bar-Sagi D. 2006. A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen. Gastroenterology 131: 1844-1855.
4. Bowman-Colin C., Xia B, Bunting S, Klijn C, Drost R, Bouwman P, Fineman L, Chen X, Culhane AC, Cai H, et al. 2013. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer. Proc Natl Acad Sci 110: 8632-8637.
5. Campbell P.J., Yachida S, Mudie LJ, Stephens PJ, Pleasance ED, Stebbings LA., Morsberger LA, Latimer C, McLaren S, Lin ML, et al. 2010. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467: 1109-1113.
6. Canto M.I., Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z., Topazian M, Takahashi N, Fletcher J, Petersen G, et al. 2012. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142: 796-804.
7. Canto M.I., Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I., Nio Y, Schulick RS, Bassi C, Kluijt I, et al. 2013. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 62: 339-347.
8. Cohn J.A., Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. 1998. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339: 653-658.
9. Cohn J.A., Bornstein JD, Jowell PS. 2000. Cystic fibrosis mutations and genetic predisposition to idiopathic chronic pancreatitis. Med Clin N Am 84: 621-631.
10. Goldgar DE. 1995. Analysis of familial breast cancer in genetic analysis workshop 9: Summary of findings. Genet Epidemiol 12: 833-836.
11. Gruis N.A., van der Velden PA, Sandkuijl LA, Prins DE, Weaver-Feldhaus J., Kamb A, Bergman W, Frants R. 1995. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 10: 351-353.
12. Hezel A.F., Gurumurthy S, Granot Z, Swisa A, Chu GC, Bailey G, Dor Y., Bardeesy N, Depinho RA. 2008. Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. Mol Cell Biol 28: 2414-2425.
13. Hruban R.H., Canto M, Goggins M, Schulick R, Klein AP. 2010. Update on familial pancreatic cancer. Adv Surg 44: 293-311.
14. Jones S., Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW, Lin JC, Palmisano E, Brune K, Jaffee EM, et al. 2009. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324: 217.
15. Kastrinos F., Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, Bandipalliam P, Stoffel EM, Gruber SB, Syngal S. 2009. Risk of pancreatic cancer in families with Lynch syndrome. JAMA 302: 1790-1795.
16. Kastrinos F., Steyerberg EW, Mercado R, Balmaña J, Holter S, Gallinger S., Siegmund KD, Church JM, Jenkins MA, Lindor NM, et al. 2011. The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Gastroenterology 140: 73-81.
17. Kereszturi E., Szmola R, Kukor Z, Simon P, Weiss FU, Lerch MM, Sahin-Tó th M. 2009. Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: A novel disease mechanism. Hum Mutat 30: 575-582.
18. Klein AP. 2013. Identifying people at a high risk of developing pancreatic cancer. Nat Rev Cancer 13: 66-74.
19. Klein A.P., Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus G.J., Griffin C, Cameron JL, Yeo CJ, Kern S, et al. 2004. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 64: 2634-2638.
20. Korsse S.E., Harinck F, van Lier MGF, Biermann K, Offerhaus GJA, Krak N, Looman CWN, van Veelen W, Kuipers EJ, Wagner A., et al. 2013. Pancreatic cancer risk in Peutz-Jeghers syndrome patients: A large cohort study and implications for surveillance. J Med Genet 50: 59-64.
21. Lowenfels A.B., Maisonneuve P, Cavallini G, Ammann RW, Lankisch P.G., Andersen JR, Dimagno EP, Andrén-Sandberg A, Domellöf L. 1993. Pancreatitis and the risk of pancreatic cancer: International Pancreatitis Study Group. N Engl J Med 328: 1433-1437.
22. Lucito R., Suresh S, Walter K, Pandey A, Lakshmi B, Krasnitz A, Sebat J, Wigler M, Klein AP, Brune K, et al. 2007. Copy-number variants in patients with a strong family history of pancreatic cancer. Cancer Biol Ther 6: 1592-1599.
23. Lynch H.T., Fusaro RM, Lynch JF, Brand R. 2008. Pancreatic cancer and the FAMMM syndrome. Fam Cancer 7: 103-112.
24. Ma J., Jemal A. 2013. The rise and fall of cancer mortality in the USA: Why does pancreatic cancer not follow the trend? Future Oncol 9: 917-919.
25. Ooi C.Y., Dorfman R, Cipolli M, Gonska T, Castellani C, Keenan K, Freedman S.D., Zielenski J, Berthiaume Y, Corey J, et al. 2011. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology 140: 153-161.
26. Ozcxelik H., Schmocker B, Di Nicola N, Shi XH, Langer B, Moore M, Taylor BR, Narod SA, Darlington G, Andrulis IL, et al. 1997. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet 16: 17-18.
27. Permuth-Wey J., Egan KM. 2009. Family history is a significant risk factor for pancreatic cancer: Results from a systematic review and meta-analysis. Fam Cancer 8: 109-117.
28. Petersen G.M., Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon R.Z., Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S., Gross M. 2010. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 42: 224-228.
29. Poley J.W., Kluijt I, Gouma DJ, Harinck F, Wagner A, Aalfs C, van Eijck C.H., Cats A, Kuipers EJ, Nio Y, et al. 2009. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Gastroenterology 104: 2175-2181.
30. Ranade K., Hussussian CJ, Sikorski RS, Varmus HE, Goldstein AM, Tucker MA, Serrano M, Hannon GJ, Beach D, Dracopoli NC. 1995. Mutations associated with familial melanoma impair p16INK4 function. Nat Genet 10: 114-116.
31. Rhim A.D., Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, et al. 2012. EMT and dissemination precede pancreatic tumor formation. Cell 148: 349-361.
32. Roberts N.J., Jiao Y, Yu J, Kopelovich L, Petersen GM, Bondy ML, Gallinger S., Schwartz AG, Syngal S, Cote ML, et al. 2012. ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov 2: 41-46.
33. Rosendahl J., Witt H, Szmola R, Bhatia E, Ozsvá ri B, Landt O, Schulz HU., Gress TM, Pfützer R, Löhr M, et al. 2008. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 40: 78-82.
34. Rowley M., Ohashi A, Mondal G, Mills L, Yang L, Zhang L, Sundsbak R., Shapiro V, Muders MH, Smyrk T, et al. 2011. Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent pancreatic cancer development inmice. Gastroenterology 140: 1303-1313.
35. Rustgi AK. 2007. The genetics of hereditary colon cancer. Genes Dev 21: 2525-2538.
36. Sato N., Rosty C, Jansen M, Fukushima N, Ueki T, Yeo CJ, Cameron JL., Iacobuzio-Donahue CA, Hruban RH, Goggins M. 2001. STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 159: 2017-2022.
37. Sharer N., Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J. 1998. Mutations of the cystic fibrosis gene in patients with cystic fibrosis. N Engl J Med 339: 645-652.
38. Skoulidis F., Cassidy LD, Pisupati V, Jonasson JG, Bjarnason H, Eyfjord JE., Karreth FA, Lim M, Barber LM, Clatworthy SA, et al. 2010. Germline Brca2 heterozygosity promotes Kras(G12D)-driven carcinogenesis in a murine model of familial pancreatic cancer. Cancer Cell 18: 499-509.
39. Szabo A., Sahin-Toth M. 2012. Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in the presence of chymotrypsin C. J Biol Chem 287: 20701-20710.
40. Thompson D., Easton DF, Breast Cancer Linkage Consortium. 2002. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94: 1358-1365.
41. Tischkowitz M.D., Sabbaghian N, Hamel N, Borgida A, Rosner C, Taherian N., Srivastava A, Holter S, Rothenmund H, Ghadirian P, et al. 2009. Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer. Gastroenterology 137: 1183-1186.
42. Wang W., Chen S, Brune KA, Hruban RH, Parmigiani G, Klein AP. 2007. PancPRO: Risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol 25: 1417-1422.
43. Whitcomb DC. 2013. Genetic risk factors for pancreatic disorders. Gastroenterology 144: 1292-1302.
44. Whitcomb D.C., Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK Jr, Amann ST, Toskes PP, et al. 1996. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14: 141-145.
45. Wu C., Miao X, Huang L, Che X, Jiang G, Yu D, Yang X, Cao G, Hu Z., Zhou Y, et al. 2011. Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet 44: 62-66.
46. Yadav D., Lowenfels AB. 2013. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 144: 1252-1261.
47. Zhang F., Ma J, Wu J, Ye L, Cai H, Xia B, Xiaochun Yu X. 2009. PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr Biol 19: 524-529.
48. Zuo L., Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N., Dracopoli NC. 1996. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12: 97-99.